Merit Medical Systems Q1 revenue beats estimates, raises full-year guidance

Earnings

โดย Yahoo Finance·Read original

Summary · why it matters

Merit Medical Systems reported first-quarter revenues of $381.9 million, up 7.5% year on year and exceeding analyst expectations by 1.2%. The company also beat earnings per share estimates and raised its full-year guidance, the highest raise among the four medical devices and supplies stocks tracked in the cardiology, neurology, and vascular segment. ICU Medical posted revenues of $525.8 million, down 12.3% year on year but still beating estimates by 1.2%, while Artivion's revenues grew 17.5% to $116.3 million but missed earnings estimates and provided weak guidance, sending its stock down 38.1%. Penumbra's revenues rose 15.6% to $374.8 million, topping estimates by 0.7%, though it missed earnings per share forecasts. Overall, the group's revenues beat consensus estimates by 0.9% on average, but share prices have fallen 6.2% since reporting.